PMS-IRBESARTAN-HCTZ
PHARMASCIENCE INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of PMS-IRBESARTAN-HCTZ in Canada?
A shortage of PMS-IRBESARTAN-HCTZ 25MG 300MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 4, 2026), but it has not started yet.
Why is PMS-IRBESARTAN-HCTZ not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will PMS-IRBESARTAN-HCTZ be available again?
The manufacturer's estimated resolution date is March 3, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2027-03-03
~5 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02328534
Strength
25MG 300MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
HYDROCHLOROTHIAZIDE IRBESARTAN
Tier
Unrated
Last Updated
2026-09-04
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from PHARMASCIENCE INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02303299
DIN 01999648
DIN 01999656
DIN 02028174
DIN 02025337
650MG · DIN 02527901
81MG · DIN 02433044
81MG · DIN 02244993
81MG · DIN 02394790
80MG · DIN 02009013
80MG · DIN 02238545
40MG · DIN 02399393